躁狂症

精神分裂症、躁狂症家系血SOD测定及遗传学分析

Determination of blood SOD activity in the family members of schizophrenics and mania patients and the genetic analysis

目的：评价国产卡马西平（CBZ）在躁狂症临床治疗中的实用性。

Objective : To evaluate the practicality of carbamazepine ( CBZ ) made in China in the treatment of mania .

奎硫平治疗躁狂症对照研究临床疗效的Meta分析

Meta-analysis of Clinical Effects of Quetiapine in Treatment of Manic Episode

方法采用家庭负担会谈量表（FIS）和自制量表，调查了48例抑郁症和43例躁狂症家庭照料者负担，并分析照料者与被照料者的一般人口学特征与照料负担的关系。

Methods : 48 depression and 43 mania patients ' family caregivers were evaluated with family interview schedule ( FIS ) for the their burden .

对67例躁郁症病人（躁狂症33例、抑郁症34例）及52例正常人发中Co、Cu、Zn、Fe、Mn、含量及Cu／Zn、Mn／Cu进行检测。

The concentrations of Cu , Zn , Co , Mn , Fe and Cu / Zn , Mn / Cu in hair of 67 cases of manic depressive illness ( Mania 33 , Depression 34 ) and 52 normal persons had been determined .

使用法国德龙药厂Sultopride滴剂治疗17例精神分裂症，8例躁狂症急性发作，显效率为72%；

Seventeen schizophrenic patients and 8 cases acute episodes of mania were treated with sultopride drops . The response rate was 72 % .

方法对23例符合CCMD-2-R中躁狂症诊断标准的患者进行CBZ治疗4～6周的研究，其剂量为0.6～1.2/d。

Methods 23 subjects met the CCMD-2-R criteria for manic episode were treated by CBZ with 0.6 ~ 1.2/day for 4 ~ 6 weeks . The efficacy and the efficacy indexes ( EI ) were assessed with BRMS and CGI .

34例急性躁狂症随机分配至氟哌利多组（男性11例，女性7例；年龄28±s10a）和氟哌啶醇组（男性10例，女性6例；年龄29±12a）治疗。

Thirty-four patients with acute mania were divided into group of droperidol ( M 11 , F 7 ; age 28 ± s 10 a ) and that of haloperidol ( M 10 , F6 ; age 29 ± 12 a ) at random .

有、无幻觉、妄想躁狂症的临床对照研究

Clinical comparison study between manias with hallucination and manias without hallucination

抑郁症和躁狂症患者的家庭照料者负担调查

A survey of family burden of patients with depression and mania

卡马西平和碳酸锂治疗躁狂症的比较研究

Controlled study of mania treated either with carbamazepine or lithium carbonate

早发和晚发性躁狂症的临床行为学研究

A clinical contrastive study of early onset and late onset mania

丙戊酸镁和碳酸锂治疗躁狂症对照研究

A control study about valproate magnesium and lithium carbonate for mania

目的：评估劳拉西泮对躁狂症的疗效。

AIM : To evaluate the therapeutic effect of lorazepam for mania .

躁狂症患者外周血T淋巴细胞研究

Study on T-cell subpopulation and related factors in manic patients

卡马西平治疗躁狂症近期疗效对照观察

Control Observation of Recent Curative Effects in Manic Disorder Treated With Carbamazepine

卡马西平治疗躁狂症临床分析

A clinical analysis in carbamazepine in the treatment of mania

舒托必利滴剂治疗精神分裂症及躁狂症急性发作

Sultopride drops in the treatment of schizophrenia and acute episode of mania

神经症与躁狂症患者的脑电图对比分析

A Comparison in EEG Characteristics between Neurotic and Mania Patients

苗族、布依族和汉族躁狂症的跨文化研究

A cross-ethnic study of mania in Miao , Buyi and Han ethnic groups

结论早发和晚发性躁狂症各有其临床特征。

Conclusions The early onset and late onset mania have clinical characteristics respectively .

复发性躁狂症的3年随访

Three - year follow - up of recurrent mania

目的：了解躁狂症患者的血清一氧化氮（NO）水平。

Objective : To understand the serum nitric oxide level in manic patients .

清热豁痰醒脑法治疗痰火扰神型躁狂症

Heat-Clearing , Phlegm-Eliminating and Brain-Awaking Therapy for Mania of Phlegm-Fire Disturbing Brain Syndrome

认知&行为疗法在躁狂症病人中的运用

Application of Cognition - behavior Therapy to Manic Patients

反复发作躁狂症20例

A study in recurrent mania - 20 cases report

结论儿童少年期躁狂症有其自身的特点。

Conclusion The child and adolescent patients with mania has characters by itself .

躁狂症患者血清肌酸磷酸激酶的研究

A pilot study of serum creatine phosphokinase levels in 89 patients with mania

精神躁狂症治疗的临床分析

Clinical analysis of results in treatment of psychic mania

结论：劳拉西泮可作为控制躁狂症急性发作的有效药物。

CONCLUSION : Lorazepam can be used to control acute stage of mania .